Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough Pain
CompletedPhase 1, Phase 2NCT05037539
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Randomized control trial that to comparison the efficacy of injectable fentanyl in sublingual route versus oral morphine syrup for breakthrough pain in gynecologic cancer patients with chronic cancer pain Primary outcome : to measure pain score after drug is given
Study details
- Official title
- Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough Pain in Gynecologic Cancer Patients With Chronic Cancer Pain : A Randomized Double Blind Controlled Trial
- Conditions
- Pain, Breakthrough
- Interventions
- Drug: Fentanyl Citrate 50Mcg/Ml Inj_#1
- Drug: Morphine
- Sponsor
- Department of Medical Services Ministry of Public Health of Thailand
- Start date
- 2021-06-15
- Primary completion
- 2021-12-30
- Sex
- Female
- Results posted
- No results posted in this snapshot
- Countries
- Thailand
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Gynecologic cancer patients with chronic cancer pain that use opioid drug for basal pain Exclusion Criteria: * allergy in fentanyl or morphine * abnormal cognitive function patient
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05037539